Total Body Irradiation Versus Chemotherapy Conditioning in Pediatric Acute Lymphoblastic Leukemia Patients Undergoing Hematopoietic Stem Cell Transplant: A Systematic Review and Meta-Analysis
Clinical Lymphoma Myeloma and Leukemia · 2023
DOI: 10.1016/j.clml.2023.01.004 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2023. Verfasst von Mohammad Ebad Ur Rehman und 13 weiteren Autor:innen. Beteiligte Einrichtung: Rawalpindi Medical University, Rawalpindi, Pakistan. Hauptthemen laut MEDLINE: Precursor Cell Lymphoblastic Leukemia-Lymphoma, Graft vs Host Disease, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Allogeneic hematopoietic stem cell transplant (HSCT) is indicated in pediatric patients with acute lymphoblastic leukemia (ALL) who have relapsed or are at a very high risk of relapse during first complete remission. Two types of myeloablative conditioning are employed before allogeneic HSCT: total body irradiation (TBI)-based regimens and chemotherapy (CHT) alone. This study compares the efficacy and safety of TBI-based regimens and CHT-based conditioning in pediatric, adolescent, and young adult patients with ALL (0-24 years old). TBI-based and CHT-conditioning regimens were evaluated in 4262 and 1367 patients, respectively, from 15 studies. Compared to CHT alone, TBI-based regimens were associated with better overall survival (OS), relative risk (RR) 1.21, better event-free survival (RR 1.34), and a reduced risk of relapse (RR 0.69). Both approaches had comparable risk of acute graft-versus-host disease (GVHD), grades 3 to 4 acute GVHD, chronic GVHD, and nonrelapse mortality (NRM). In the subgroup analysis for patients in first complete remission, TBI-based regimens and CHT alone had comparable OS and NRM. Our results demonstrate the superiority of TBI-based regimens compared to CHT alone in pediatric patients with ALL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Rawalpindi Medical University, Rawalpindi, Pakistan.
- Department of Internal Medicine, University of Pittsburgh Medical Center, Mckeesport, PA.
- Sharif Medical and Dental College, Lahore, Pakistan.
- Loyola Medicine MacNeal Hospital, Berwyn, IL.
- Division of Pathology, ICAR-Indian Veterinary Research Institute (IVRI), Bareilly, Uttar Pradesh, India.
- Maroof International Hospital, Islamabad, Pakistan.
Zitieren
APA
Rehman, M. E. U., Chattaraj, A., Mahboob, A., Ijaz, Z., Franco, D., Farhan, M., Dharma, K., Mumtaz, H., Saeed, S., Basit, J., Aslam, M. M., Iftikhar, A., Faraz, F., & Anwer, F. (2023). Total Body Irradiation Versus Chemotherapy Conditioning in Pediatric Acute Lymphoblastic Leukemia Patients Undergoing Hematopoietic Stem Cell Transplant: A Systematic Review and Meta-Analysis. Clinical Lymphoma Myeloma and Leukemia. https://doi.org/10.1016/j.clml.2023.01.004
Vancouver
Rehman MEU, Chattaraj A, Mahboob A, Ijaz Z, Franco D, Farhan M, et al. Total Body Irradiation Versus Chemotherapy Conditioning in Pediatric Acute Lymphoblastic Leukemia Patients Undergoing Hematopoietic Stem Cell Transplant: A Systematic Review and Meta-Analysis. Clinical Lymphoma Myeloma and Leukemia. 2023. doi:10.1016/j.clml.2023.01.004
BibTeX
@article{Rehman2023,
author = {Rehman, Mohammad Ebad Ur and Chattaraj, Asmi and Mahboob, Anber and Ijaz, Zarnab and Franco, Diana and Farhan, Muhammad and Dharma, Kuldeep and Mumtaz, Hassan and Saeed, Sajeel and Basit, Jawad and Aslam, Muhammad Muaaz and Iftikhar, Ahmad and Faraz, Fatima and Anwer, Faiz},
title = {Total Body Irradiation Versus Chemotherapy Conditioning in Pediatric Acute Lymphoblastic Leukemia Patients Undergoing Hematopoietic Stem Cell Transplant: A Systematic Review and Meta-Analysis},
journal = {Clinical Lymphoma Myeloma and Leukemia},
year = {2023},
doi = {10.1016/j.clml.2023.01.004}
}
EUVIMED